摘要
目的:研究冠心病(CHD)患者冠脉循环中血浆线粒体偶联因子-6(MCF-6)含量与冠脉狭窄程度的相关性。方法:选择冠心病患者64例(冠心病组),根据冠脉病变程度分为单支、双支、多支病变组;另选冠脉正常者20例作为正常对照组,用放免方法分别测定各组外周、冠状窦、冠状窦与主动脉根部血浆MCF-6浓度,并用多元线性逐步回归分析分析冠脉循环血浆MCF-6含量与冠脉狭窄程度的相关性。结果:冠心病患者外周、主动脉根部、冠状窦血浆MCF-6浓度较正常对照组均显著升高(P〈0.05);冠心病组冠状窦血浆MCF-6浓度较主动脉根部及外周血的均显著升高[(402±56)pg/ml比(348±48)pg/ml比(340±51)pg/ml,P〈0.01];多支病变组的血浆MCF-6浓度较单支、双支病变组的显著升高(P〈0.05~0.01);多元线性逐步回归分析显示冠状窦及主动脉根部血浆MCF-6浓度与Gensini积分均呈明显正相关(r=0.650,P〈0.01;r=0.711,P〈0.01)。结论:线粒体偶联因子-6参与了冠心病的病理生理过程,在冠心病的发病过程中可能是一种较为重要的血管活性物质。
Objective: To study correlation between plasma mitochondrial coupling factor-6 (MCF-6) level in coronary circulation and coronary stenotic degree in CHD patients. Methods: A total of 64 CHD patients were selected as CHD group, and they were further divided into single-vessel group, double-vessel group and multi-vessel coronary disease group; another 20 cases with normal coronary artery were enrolled as normal control group. Radioimmunoassay method was used to measure plasma MCF-6 concentration in peripheral, coronary sinus and aortic root in each group. Multivariant linear gradual regressive analysis was used to analyze above-mentioned correlation. Results: Compared with normal control group, there was significant increase in plasma MCF-6 concentration in peripheral, aortic root and coronary sinus in CHD patients (P〈0.05 all) ; compared with aortic root and peripheral plasma, there was significant increase in MCF-6 concentration [(348±48) pg/ml vs. (340±51) pg/ml vs. (402±56) pg/ml, P〈0.01 all] in coronary sinus of CHD group; Compared with single-vessel group, double-vessel group, there were increase in MCF-6 concentration in multi-vessel coronary disease group (P 〈 0.05 -〈0.01) ; Multivariant linear gradual regressive analysis indicated that Gensini score was significant positively correlated with plasma MCF-6 concentrations in coronary sinus and aortic root ( r = 0. 650, P〈0.01 ; r = 0.711, P〈0.01). Conclusion: Mitochondrial coupling factor-6 participates in the pathophysiological process of coronary heart disease, which may be an important vasoactive substance during development of coronary heart disease.
出处
《心血管康复医学杂志》
CAS
2014年第2期117-122,共6页
Chinese Journal of Cardiovascular Rehabilitation Medicine